-
1
Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy
Published 2020-07-01Subjects: Get full text
Article -
2
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression
Published 2023-11-01Subjects: Get full text
Article -
3
Targeting Dual Immune Checkpoints PD‐L1 and HLA‐G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer
Published 2024-11-01Subjects: “…nanobody‐based trispecific T cell engager (Nb‐TriTE)…”
Get full text
Article -
4
Improving the tumor selectivity of T cell engagers by logic-gated dual tumor-targeting
Published 2023-06-01Subjects: “…Trispecific T cell engagers…”
Get full text
Article